[O8] Oral Presentations 8

2:05 PM - 2:15 PM JST(5:05 AM - 5:15 AM UTC)Vaccine Science

[O8-06] A next-generation mRNA vaccine platform enabling rapid neutralizing antibody responses

*Takayuki Matsumura¹, Sayuri Nakahara², Daiki Oka², Tomohiro Takano¹, Kazutaka Terahara¹, Masanori Isogawa³, Yoshimasa Takahashi¹ (1. Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 2. Meiji Seika Pharma Co., Ltd (Japan), 3. Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan))

Keywords:

mRNA vaccine,Lipid nanoparticle,T cell epitopes,Antibody responses,Influenza viruses

Password required to view

Log in

or